HEADER TRANSFERASE 02-JUL-03 1PX5 TITLE CRYSTAL STRUCTURE OF THE 2'-SPECIFIC AND DOUBLE-STRANDED TITLE 2 RNA-ACTIVATED INTERFERON-INDUCED ANTIVIRAL PROTEIN 2'-5'- TITLE 3 OLIGOADENYLATE SYNTHETASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2'-5'-OLIGOADENYLATE SYNTHETASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: (2-5')OLIGO(A)SYNTHETASE 1, 2-5A SYNTHETASE 1, COMPND 5 P42 OAS; COMPND 6 EC: 2.7.7.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 GENE: OAS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS 5-STRANDED ANTIPARALEL BETA SHEET, FOUR HELIX BUNDLE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.HARTMANN,J.JUSTESEN,S.N.SARKAR,G.C.SEN,V.C.YEE REVDAT 2 24-FEB-09 1PX5 1 VERSN REVDAT 1 25-NOV-03 1PX5 0 JRNL AUTH R.HARTMANN,J.JUSTESEN,S.N.SARKAR,G.C.SEN,V.C.YEE JRNL TITL CRYSTAL STRUCTURE OF THE 2'-SPECIFIC AND JRNL TITL 2 DOUBLE-STRANDED RNA-ACTIVATED INTERFERON-INDUCED JRNL TITL 3 ANTIVIRAL PROTEIN 2'-5'-OLIGOADENYLATE SYNTHETASE JRNL REF MOL.CELL V. 12 1173 2003 JRNL REFN ISSN 1097-2765 JRNL PMID 14636576 JRNL DOI 10.1016/S1097-2765(03)00433-7 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 69379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4925 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 10408 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 820 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5460 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 770 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.54000 REMARK 3 B22 (A**2) : -2.50000 REMARK 3 B33 (A**2) : -5.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.51000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.72 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.290 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.210 ; 3.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.320 ; 3.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.850 ; 4.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 43.62 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_MOD.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PX5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUL-03. REMARK 100 THE RCSB ID CODE IS RCSB019659. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-DEC-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69379 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 19.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 32.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 2000MME, SODIUM CACODYLATE, REMARK 280 AMMONIUM SULFATE, SODIUM CHLORIDE, PH 6.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 66.30050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 48 REMARK 465 ALA A 49 REMARK 465 ASP A 50 REMARK 465 GLY A 64 REMARK 465 LYS A 65 REMARK 465 GLY A 66 REMARK 465 THR A 67 REMARK 465 THR A 68 REMARK 465 LEU A 69 REMARK 465 ARG A 70 REMARK 465 GLY A 71 REMARK 465 ARG A 124 REMARK 465 ARG A 125 REMARK 465 GLU A 126 REMARK 465 ASN A 127 REMARK 465 PRO A 128 REMARK 465 ARG A 129 REMARK 465 GLN A 347 REMARK 465 LYS A 348 REMARK 465 ILE A 349 REMARK 465 THR B 67 REMARK 465 THR B 68 REMARK 465 LEU B 69 REMARK 465 ARG B 124 REMARK 465 ARG B 125 REMARK 465 GLU B 126 REMARK 465 ASN B 127 REMARK 465 PRO B 128 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 45 27.19 48.65 REMARK 500 ASN A 199 46.59 -80.52 REMARK 500 SER A 244 -73.03 -135.05 REMARK 500 ASP A 312 67.68 -154.69 REMARK 500 LYS B 65 73.26 77.49 REMARK 500 SER B 244 -66.18 -137.26 REMARK 500 LYS B 264 30.27 -95.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 998 DISTANCE = 7.31 ANGSTROMS REMARK 525 HOH A1003 DISTANCE = 7.07 ANGSTROMS REMARK 525 HOH A1117 DISTANCE = 7.84 ANGSTROMS REMARK 525 HOH B1125 DISTANCE = 5.65 ANGSTROMS REMARK 525 HOH A1134 DISTANCE = 6.19 ANGSTROMS REMARK 525 HOH B1146 DISTANCE = 5.52 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 801 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 802 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 803 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 804 DBREF 1PX5 A 1 349 UNP Q29599 OAS1_PIG 1 349 DBREF 1PX5 B 1 349 UNP Q29599 OAS1_PIG 1 349 SEQADV 1PX5 YCM A 24 UNP Q29599 CYS 24 MODIFIED RESIDUE SEQADV 1PX5 YCM A 37 UNP Q29599 CYS 37 MODIFIED RESIDUE SEQADV 1PX5 YCM B 24 UNP Q29599 CYS 24 MODIFIED RESIDUE SEQADV 1PX5 YCM B 37 UNP Q29599 CYS 37 MODIFIED RESIDUE SEQRES 1 A 349 MET GLU LEU ARG HIS THR PRO ALA ARG ASP LEU ASP LYS SEQRES 2 A 349 PHE ILE GLU ASP HIS LEU LEU PRO ASN THR YCM PHE ARG SEQRES 3 A 349 THR GLN VAL LYS GLU ALA ILE ASP ILE VAL YCM ARG PHE SEQRES 4 A 349 LEU LYS GLU ARG CYS PHE GLN GLY THR ALA ASP PRO VAL SEQRES 5 A 349 ARG VAL SER LYS VAL VAL LYS GLY GLY SER SER GLY LYS SEQRES 6 A 349 GLY THR THR LEU ARG GLY ARG SER ASP ALA ASP LEU VAL SEQRES 7 A 349 VAL PHE LEU THR LYS LEU THR SER PHE GLU ASP GLN LEU SEQRES 8 A 349 ARG ARG ARG GLY GLU PHE ILE GLN GLU ILE ARG ARG GLN SEQRES 9 A 349 LEU GLU ALA CYS GLN ARG GLU GLN LYS PHE LYS VAL THR SEQRES 10 A 349 PHE GLU VAL GLN SER PRO ARG ARG GLU ASN PRO ARG ALA SEQRES 11 A 349 LEU SER PHE VAL LEU SER SER PRO GLN LEU GLN GLN GLU SEQRES 12 A 349 VAL GLU PHE ASP VAL LEU PRO ALA PHE ASP ALA LEU GLY SEQRES 13 A 349 GLN TRP THR PRO GLY TYR LYS PRO ASN PRO GLU ILE TYR SEQRES 14 A 349 VAL GLN LEU ILE LYS GLU CYS LYS SER ARG GLY LYS GLU SEQRES 15 A 349 GLY GLU PHE SER THR CYS PHE THR GLU LEU GLN ARG ASP SEQRES 16 A 349 PHE LEU ARG ASN ARG PRO THR LYS LEU LYS SER LEU ILE SEQRES 17 A 349 ARG LEU VAL LYS HIS TRP TYR GLN THR CYS LYS LYS THR SEQRES 18 A 349 HIS GLY ASN LYS LEU PRO PRO GLN TYR ALA LEU GLU LEU SEQRES 19 A 349 LEU THR VAL TYR ALA TRP GLU GLN GLY SER ARG LYS THR SEQRES 20 A 349 ASP PHE SER THR ALA GLN GLY PHE GLN THR VAL LEU GLU SEQRES 21 A 349 LEU VAL LEU LYS HIS GLN LYS LEU CYS ILE PHE TRP GLU SEQRES 22 A 349 ALA TYR TYR ASP PHE THR ASN PRO VAL VAL GLY ARG CYS SEQRES 23 A 349 MET LEU GLN GLN LEU LYS LYS PRO ARG PRO VAL ILE LEU SEQRES 24 A 349 ASP PRO ALA ASP PRO THR GLY ASN VAL GLY GLY GLY ASP SEQRES 25 A 349 THR HIS SER TRP GLN ARG LEU ALA GLN GLU ALA ARG VAL SEQRES 26 A 349 TRP LEU GLY TYR PRO CYS CYS LYS ASN LEU ASP GLY SER SEQRES 27 A 349 LEU VAL GLY ALA TRP THR MET LEU GLN LYS ILE SEQRES 1 B 349 MET GLU LEU ARG HIS THR PRO ALA ARG ASP LEU ASP LYS SEQRES 2 B 349 PHE ILE GLU ASP HIS LEU LEU PRO ASN THR YCM PHE ARG SEQRES 3 B 349 THR GLN VAL LYS GLU ALA ILE ASP ILE VAL YCM ARG PHE SEQRES 4 B 349 LEU LYS GLU ARG CYS PHE GLN GLY THR ALA ASP PRO VAL SEQRES 5 B 349 ARG VAL SER LYS VAL VAL LYS GLY GLY SER SER GLY LYS SEQRES 6 B 349 GLY THR THR LEU ARG GLY ARG SER ASP ALA ASP LEU VAL SEQRES 7 B 349 VAL PHE LEU THR LYS LEU THR SER PHE GLU ASP GLN LEU SEQRES 8 B 349 ARG ARG ARG GLY GLU PHE ILE GLN GLU ILE ARG ARG GLN SEQRES 9 B 349 LEU GLU ALA CYS GLN ARG GLU GLN LYS PHE LYS VAL THR SEQRES 10 B 349 PHE GLU VAL GLN SER PRO ARG ARG GLU ASN PRO ARG ALA SEQRES 11 B 349 LEU SER PHE VAL LEU SER SER PRO GLN LEU GLN GLN GLU SEQRES 12 B 349 VAL GLU PHE ASP VAL LEU PRO ALA PHE ASP ALA LEU GLY SEQRES 13 B 349 GLN TRP THR PRO GLY TYR LYS PRO ASN PRO GLU ILE TYR SEQRES 14 B 349 VAL GLN LEU ILE LYS GLU CYS LYS SER ARG GLY LYS GLU SEQRES 15 B 349 GLY GLU PHE SER THR CYS PHE THR GLU LEU GLN ARG ASP SEQRES 16 B 349 PHE LEU ARG ASN ARG PRO THR LYS LEU LYS SER LEU ILE SEQRES 17 B 349 ARG LEU VAL LYS HIS TRP TYR GLN THR CYS LYS LYS THR SEQRES 18 B 349 HIS GLY ASN LYS LEU PRO PRO GLN TYR ALA LEU GLU LEU SEQRES 19 B 349 LEU THR VAL TYR ALA TRP GLU GLN GLY SER ARG LYS THR SEQRES 20 B 349 ASP PHE SER THR ALA GLN GLY PHE GLN THR VAL LEU GLU SEQRES 21 B 349 LEU VAL LEU LYS HIS GLN LYS LEU CYS ILE PHE TRP GLU SEQRES 22 B 349 ALA TYR TYR ASP PHE THR ASN PRO VAL VAL GLY ARG CYS SEQRES 23 B 349 MET LEU GLN GLN LEU LYS LYS PRO ARG PRO VAL ILE LEU SEQRES 24 B 349 ASP PRO ALA ASP PRO THR GLY ASN VAL GLY GLY GLY ASP SEQRES 25 B 349 THR HIS SER TRP GLN ARG LEU ALA GLN GLU ALA ARG VAL SEQRES 26 B 349 TRP LEU GLY TYR PRO CYS CYS LYS ASN LEU ASP GLY SER SEQRES 27 B 349 LEU VAL GLY ALA TRP THR MET LEU GLN LYS ILE MODRES 1PX5 YCM A 24 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 1PX5 YCM A 37 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 1PX5 YCM B 24 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 1PX5 YCM B 37 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HET YCM A 24 10 HET YCM A 37 10 HET YCM B 24 10 HET YCM B 37 10 HET SO4 A 801 5 HET SO4 B 802 5 HET SO4 A 803 5 HET SO4 B 804 5 HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM SO4 SULFATE ION HETSYN YCM CYSTEINE-S-ACETAMIDE FORMUL 1 YCM 4(C5 H10 N2 O3 S) FORMUL 3 SO4 4(O4 S 2-) FORMUL 7 HOH *770(H2 O) HELIX 1 1 GLU A 2 THR A 6 5 5 HELIX 2 2 PRO A 7 ARG A 9 5 3 HELIX 3 3 ASP A 10 LEU A 19 1 10 HELIX 4 4 ASN A 22 CYS A 44 1 23 HELIX 5 5 GLU A 88 ARG A 93 1 6 HELIX 6 6 ARG A 93 GLN A 112 1 20 HELIX 7 7 ASN A 165 GLY A 180 1 16 HELIX 8 8 PHE A 185 CYS A 188 5 4 HELIX 9 9 PHE A 189 ASN A 199 1 11 HELIX 10 10 PRO A 201 LYS A 220 1 20 HELIX 11 11 PRO A 228 SER A 244 1 17 HELIX 12 12 SER A 250 LYS A 264 1 15 HELIX 13 13 HIS A 265 LYS A 267 5 3 HELIX 14 14 ASN A 280 LYS A 292 1 13 HELIX 15 15 ASP A 312 LEU A 327 1 16 HELIX 16 16 GLY A 328 LYS A 333 5 6 HELIX 17 17 GLU B 2 THR B 6 5 5 HELIX 18 18 PRO B 7 ARG B 9 5 3 HELIX 19 19 ASP B 10 LEU B 19 1 10 HELIX 20 20 ASN B 22 CYS B 44 1 23 HELIX 21 21 GLU B 88 ARG B 93 1 6 HELIX 22 22 ARG B 93 GLN B 112 1 20 HELIX 23 23 ASN B 165 GLY B 180 1 16 HELIX 24 24 PHE B 185 CYS B 188 5 4 HELIX 25 25 PHE B 189 ASN B 199 1 11 HELIX 26 26 PRO B 201 GLY B 223 1 23 HELIX 27 27 PRO B 228 SER B 244 1 17 HELIX 28 28 SER B 250 LYS B 264 1 15 HELIX 29 29 HIS B 265 LYS B 267 5 3 HELIX 30 30 ASN B 280 LYS B 292 1 13 HELIX 31 31 ASP B 312 LEU B 327 1 16 HELIX 32 32 GLY B 328 LYS B 333 5 6 HELIX 33 33 TRP B 343 GLN B 347 5 5 SHEET 1 A 5 ARG A 53 SER A 62 0 SHEET 2 A 5 SER A 73 THR A 82 -1 O VAL A 78 N VAL A 58 SHEET 3 A 5 GLU A 143 PHE A 152 1 O ASP A 147 N LEU A 77 SHEET 4 A 5 SER A 132 SER A 136 -1 N PHE A 133 O PHE A 146 SHEET 5 A 5 THR A 117 VAL A 120 -1 N THR A 117 O SER A 136 SHEET 1 B 2 CYS A 269 ILE A 270 0 SHEET 2 B 2 VAL A 297 ILE A 298 1 O VAL A 297 N ILE A 270 SHEET 1 C 5 VAL B 54 SER B 62 0 SHEET 2 C 5 ARG B 72 LEU B 81 -1 O VAL B 78 N VAL B 58 SHEET 3 C 5 GLN B 142 PHE B 152 1 O ASP B 147 N LEU B 77 SHEET 4 C 5 SER B 132 SER B 137 -1 N SER B 137 O GLN B 142 SHEET 5 C 5 THR B 117 VAL B 120 -1 N THR B 117 O SER B 136 SHEET 1 D 2 CYS B 269 ILE B 270 0 SHEET 2 D 2 VAL B 297 ILE B 298 1 O VAL B 297 N ILE B 270 LINK C THR A 23 N YCM A 24 1555 1555 1.33 LINK C YCM A 24 N PHE A 25 1555 1555 1.33 LINK C VAL A 36 N YCM A 37 1555 1555 1.33 LINK C YCM A 37 N ARG A 38 1555 1555 1.33 LINK C THR B 23 N YCM B 24 1555 1555 1.32 LINK C YCM B 24 N PHE B 25 1555 1555 1.34 LINK C VAL B 36 N YCM B 37 1555 1555 1.33 LINK C YCM B 37 N ARG B 38 1555 1555 1.33 CISPEP 1 ARG A 295 PRO A 296 0 0.86 CISPEP 2 ARG B 295 PRO B 296 0 0.41 SITE 1 AC1 10 ARG A 103 ALA A 107 ARG A 110 LYS A 246 SITE 2 AC1 10 HOH A 833 HOH A 835 HOH A 890 HOH A 928 SITE 3 AC1 10 HOH A 937 HOH A 986 SITE 1 AC2 5 GLN B 46 ARG B 53 LYS B 246 HOH B 894 SITE 2 AC2 5 HOH B1035 SITE 1 AC3 2 ARG A 295 HOH A1155 SITE 1 AC4 2 ARG B 38 HOH B 849 CRYST1 46.524 132.601 57.305 90.00 99.19 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021494 0.000000 0.003477 0.00000 SCALE2 0.000000 0.007541 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017677 0.00000